ProxivirTM
Tenofovir Disoproxil Fumarate
Hepatitis Antivirals (Systemic Antiviral)
Indication:
ProxivirTM is indicated for the treatment of:
Chronic hepatitis B virus infection in adults
HIV infected adults in combination with other anti-retroviral agents
Dosage & Administration:
The recommended dose of Tenofovir in chronic hepatitis B virus infection in patients 12 years of age and older with adequate renal function is 300 mg once daily with or without food. Dose adjustment in renal impairment: Tenofovir is eliminated by renal excretion, so the exposure to Tenofovir increases in patients with renal dysfunction.
Preparation:
ProxivirTM Tablet: Each box contains 12 tablets in Alu-Alu blister pack.
